Simultaneously, by modulating store-operated Ca2+ entry and mitochondrial buffering capacity, these compounds bolster insulin responsiveness, elevate energy expenditure and optimize lipid metabolism, underscoring their promise in battling obesity and metabolic syndrome [52]. The gene discussed is INS; the disease is metabolic syndrome.